Clinical Trial Update: TRISCEND II Pivotal Trial [NA]

View source ↗

Summary

Edwards Lifesciences reports that the TRISCEND II pivotal trial for tricuspid valve disease is currently active but not recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cardiovascular Disease
• Heart Failure
• Heart Valve Disease
• Tricuspid Valve Disease
• Tricuspid Valve Insufficiency
• Tricuspid Valve Regurgitation

Snippet

Sponsor: Edwards Lifesciences | Conditions: Tricuspid Valve Regurgitation, Tricuspid Valve Insufficiency | NA | Status: ACTIVE_NOT_RECRUITING